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Abstract
Central nervous system (CNS) characteristics were examined in seventeen patients with autosomal recessive classic or “pure55 
congenital muscular dystrophy (CMD). In three patients, neuroradiological examination (C T /M R I) indicated hypodense white 
matter areas. Two out of these three patients had epilepsy (seizures and epileptic discharges on their EEG). Only two of the 
remaining patients had epileptic E E G  discharges, but without clinical seizures. By comparing our results to data in the literature, 
we could conclude that the classic or “pure” form of CM D can be subdivided into two subtypes, i.e. those with and those without 
white matter hypodensities. A mild form of epilepsy or an epileptic predisposition on EEG  can be part of the subtype with white 
matter hypodensities.
Keywords: Congenital muscular dystrophy; Type 1 congenital muscular dystrophy; Cerebral white matter hypodensity; (Subnor­
mal intelligence; Epilepsy
1. Introduction
Congenital muscular dystrophy (CMD) has been 
used to describe a group of neuromuscular disorders 
characterized by autosomal recessive inheritance, onset 
at birth or during the first year of life, hypotonia and 
generalized muscular weakness, multiple joint contrac­
tures evident in the first year of life, non-progressive or 
slowly progressive clinical course, (sub)normal mental 
development, and muscle biopsies which show striking 
pathological changes similar to muscular dystrophy and 
a normal distribution of dystrophin (Fukuyama et al., 
1960, 1981; Gubbay et al., 1966; Vassella et al., 1970; 
Donner et al., 1975; Lazaro et aL, 1979; Serratrice et 
al., '1980; McMenamin et al., -1982; Banker, 1986; 
Dubowitz, 1994)» CMD has been classified into three 
separate entities (Dubowitz, 1994): classic or “pure”
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CMD with (sub)normal intelligence, Fukuyama type of 
CMD (F-CMD) with cerebral abnormalities and severe 
mental retardation (Fukuyama et al., I960, 1981), and 
“muscle-ey e-brain disease” (MEB-D) (Raitta et al., 
1978; Santavuori et aL, 1989; Leyten et al., 1991, 1992)
or the “cerebro-ocular dysplasia-muscular dystrophy 
syndrome1’ (COD-MD) (Towfighi et aL, 1984; Heggie 
et al,, 1987; Federico et al,, 1988) with severe mental 
retardation and ocular malformations. The Walker- 
Warburg syndrome (WWS) is an autosomal recessive 
disorder characterized by type II lissencephaly, cere­
bellar malformation, characteristic eye malformations 
and congenital muscular dystrophy (McKusick, 1988). 
At present, there is still no consensus about whether 
MEB-D and WWS are separate entities (Dubowitz, 
1994). Some authors consider that MEB-D and WWS 
only differ in severity rather than in any fundamental 
feature (Dobyns et aL, 1985; Leyten et aL, 1989).
Recently, there have been 14 reports on 64 patients 
with a “pure” CMD and (sub)normal intelligence, 
whose CT/MRI scans indicated marked hypodensity 
of the white matter (Bernier et aL, 1979; Nogen, 1980;
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Egger et al.5 1983; Echenne et al., 1986; Martinelli et 
al., 1987; Yoshioka et al., 1987; Castro-Gago and 
Pena-Guitian, 1988; Streib and Lucking, 1989; Tanaka 
et al., 1990; Cook et al., 1992; Kacinski et al., 1992; 
Pihko et al., 1992; Donner [see Dubowitz, 1994]; Topa- 
loglu et al., 1994). Topaloglu. et al. (1994) suggested 
that this type should be considered as an intermediate 
form between the “pure” form of CMD and the 
Fukuyama type of CMD, referred to by them as “occi­
dental type cerebromuscular dystrophy”. At present, 
cases with a (sub)normal intelligence quotient (IQ) who 
show white matter hypodensity on CT or MRI exami­
nation are included into the “pure” form of CMD 
(Dubowitz, 1994).
We analyzed the CT/MRI of our 17 patients with 
“pure” CMD and found 3 cases with white matter 
hypodensities. The clinical, electrophysiological and 
neuroradiological data on these patients were com­
pared to those reported in the literature.
2. Materials and methods
In a retrospective study on a consecutive series of 
2010 patients who underwent muscle biopsy because of 
muscle weakness, we found 17 patients with CMD. The 
final diagnosis was based on diagnostic criteria for 
classic or “pure” CMD (see Table 1) (Dubowitz, 1994). 
CNS characteristics of these patients were analyzed, 
including the clinical signs and symptoms, IQ, cere­
brospinal fluid (CSF) (9 patients), especially myelin 
basic protein (MBP), EEG, and neuroradiological find­
ings (CT/MRI). DNA analysis including examination 
of the Xp 21 dystrophy gen was performed on all of the 
boys with a serum creatine kinase (CK) level of above 
150 U /l (normal, <100 U/l), on some of the boys 
with a normal CK level and on two of the girls.
2.1. Report of 3 CMD cases with white matter hypodensi­
ties
Case 15
This 21-year-old man was the only child of healthy 
non-consanguineous parents. Family history did not 
mention neuromuscular disorders. Pregnancy was un­
eventful with normal intrauterine movements. Birth 
weight was 2870 g. At birth, generalized weakness and 
hypotonia, facies myopathica and contractures of the 
hips were found. Respiration was poor during the 
neonatal period. Motor development was delayed; the 
patient sat without support at 36 months and pulled 
himself upright at 40 months. He did not learn to stand 
and walk without support. Intellectual development 
was normal.
On admission at 3 years of age, muscle weakness 
and hypotonia were severe and diffuse, but muscle 
wasting was not obvious. His face was without expres­
sion. Flexion contractures of the elbow, knee, hip and 
ankle joints were present. Right concave scoliosis was 
found. The only abnormal neurological signs comprised 
absent tendon reflexes, while the plantar responses 
were flexor. There were no dysmorphic features and 
the head circumference was on the 50th percentile. His 
mental development was considered to be above aver­
age until the age of 3 years.
On examination at the age of 13 years, there was no 
evidence of progression of the muscle weakness, The 
Wechsler Intelligence Scale for Children-Revised 
(WISC-R) revealed a full scale IQ  score of 115.
At the age of 20 years, muscle weakness was static. 
He did not show deterioration in intelligence and be­
haviour. At this age, he had suffered two generalized 
tonic-clonic grand mal epileptic seizure. Over the last 
four years he developed progressive thoracic scoliosis.
Biochemical investigations of serum and urine gave
Table 1
Diagnostic criteria for classic or “pure” CMD.
Inclusion criteria Exclusion criteria
Clinical features:
— onset at birth or during the first year of life,
— hypotonia and generalized muscular weakness,
— multiple joint contractures evident in the first year of life,
— clinical course non-progressive or slowly progressive,
— normal or subnormal mental development.
Muscle biopsy:
— dystrophic pattern,
— marked increase in interstitial connective tissue with 
or without increase in interstitial adipose tissue,
— no marked fibre necrosis and regenerative activity,
— sometimes more pronounced dystrophic pattern, with evident 
necrosis and regeneration; dystrophin (both immunocytochemical 
and Western blot) must be present and normal.
Clinical features:
— onset during childhood,
— clinical course rapidly progressive,
— muscular hypertrophy,
— ptosis a n d /o r  ophthalmoplegia,
— severe impairment o f intellectual development (IQ < 50),
— ocular abnormalities.
Laboratory findings:
— E M G  with “ neuropathic” pattern,
— muscle biopsy normal, with neuropathic abnormalities or with 
structural abnormalities specific of other myopathies,
— dystrophin absent or abnormal,
— major CT or MRI abnormalities o f CNS different from white matter 
hypodensity (major malformations, developmental a n d /o r  
migration defects),
— ocular abnormalities showed by ophthalmological examination.
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normal values except for a serum CK of 400 U /l 
(normal, < 100 U/l). Full blood count, electrolytes, 
lactate and pyruvate levels in serum and CSF, blood 
and urine amino acids, copper, long chain fatty acids, 
white cell lysosomal enzymes and organic acids were 
normal. Microbiological examination excluded infec­
tions such as toxoplasma, cytomegalovirus, herpes or
rubella virus. Chromosome analysis revealed a normal
k
46,XY karyotype. Rearrangements of the dystrophy 
gen at Xp21 were not found.
Electromyography (EMG) revealed an increased 
number of brief polyphasic potentials with a small 
amplitude. Motor nerve conduction velocities were 
normal. EEG showed rhythmic activity which was poor 
for his age and multifocal discharges. VEP and SSEP 
were normal.
A  biopsy from the quadriceps muscle at the age of 3 
years showed a wide variation in fibre diameters; many 
of the fibres were larger than normal. Degenerative 
changes were present with central nuclei and fibre 
splitting. There was an increase in the interstitial con­
nective tissue and some fat replacement.
Cerebral CT at the age of 13 years showed marked 
hypodensity of the white matter of both hemispheres, 
which could also be seen on MRI, There has been no 
progression in white matter hypodensities on CT/MRI 
during the past 5 years.
Case 16
A boy, the third child of healthy consanguineous 
parents (second cousins), was born after an uneventful 
pregnancy and normal intrauterine movements. Family 
history did not mention any neuromuscular disorders. 
Birth weight was 3925 g. Postpartum period was not 
complicated by asphyxia. At birth, generalized weak­
ness and hypotonia, facies myopathica and contrac­
tures were found. Since the age of 2 years, he has been 
receiving (successful) treatment with antiepileptic drugs 
for partial complex epileptic seizures, sometimes with 
secondary generalization.
On examination at the age of 6 years, his head 
circumference was 55 cm ( > P90) and strabismus diver- 
gens was noted, without any structural ocular malfor­
mations. Generalized hypotonia and muscle weakness, 
which affected the proximal and distal muscles equally, 
were present with “facies myopathica”. Deep tendon 
reflexes could not be elicited. Examination of the feet 
revealed “pedes equinovarus adducti” with toe-walk­
ing. Further development was characterized by motor 
retardation and contractures of the achilles tendons 
which necessitated tendon lengthening procedures. At 
the age of 7 years, he became wheelchair-dependent. 
Over the past 8 years he has developed progressive 
thoracolumbar scoliosis which required spondylodesis. 
At present he is 22 years old and wheelchair-depen­
dent. He did not show any deterioration in intelligence 
and behaviour.
Biochemical investigations of serum and urine gave 
normal values (CK, 67 U/l). Full blood count, elec­
trolytes, lactate and pyruvate levels in serum and CSF, 
blood and urine amino acids, copper, long chain fatty 
acids, white cell lysosomal enzymes and organic acids 
were normal. Microbiological examination excluded in­
fections such as toxoplasma, cytomegalovirus, herpes 
or rubella virus. Chromosome analysis revealed a nor­
mal 46,XY karyotype. Rearrangements of the dystro­
phy gen at Xp21 were not found.
EMG revealed an increased number of brief 
polyphasic potentials with a small amplitude. Motor 
nerve conduction velocities were normal. EEG showed 
diffuse slowing of the background and paroxysmal 
epileptic discharges.
A biopsy from the quadriceps muscle at the age of 
six years revealed dystrophic changes, such as in­
creased variability of muscle fibre size, severe increase 
of fat cells, basophilic fibres and fibres with internal 
nuclei and an increased amount of interstitial connec­
tive tissue.
Fig. 1. Cerebral CT scan of case 16 showing diffuse hypodensity of 
the white matter.
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Cerebral CT at the age of 12 years showed diffuse 
hypodensity of the white matter (Fig. 1). MRI of the 
brain was not performed. No progression of the white 
matter hypodensities has been seen on CT during the 
past 3 years.
Case 17
A girl, the third child of healthy non-consangui- 
neous parents, was born after an uneventful pregnancy 
with normal intrauterine movements. Family history 
did not mention any neuromuscular disorders. Birth 
weight was 3360 grams and the Apgar scores were 9 
and 10. Postpartum period was not complicated by 
asphyxia. At birth, generalized weakness and hypoto­
nia, facies myopathica and slight dysplasia of the left 
hip were found. Deep tendon reflexes were absent. 
Head circumference was normal for her age. Ophthal- 
mological examination did not reveal any structural 
malformations. At the age of 3 months, torticollis was 
noted, which necessitated operative correction at the 
age of 7 months. By the age of 18 months she was able 
to crawl, but could not stand. Generalized areflexia, 
hypotonia and muscle weakness were obvious, espe­
cially in the proximal musculature. Contractures did 
not occur. Mental development was normal. The fol­
lowing examinations were performed at this age of 18 
months.
Biochemical investigations of serum and urine gave 
normal values, except for increased CK (1178 U /l, 
normal < 90). Full blood count, electrolytes, lactate 
and pyruvate levels in serum and CSF, blood and urine 
amino acids, copper, long chain fatty acids, white cell 
lysosomal enzymes and organic acids were normal. 
Microbiological examination excluded infections such 
as toxoplasma, cytomegalovirus, herpes or rubella virus. 
Chromosome analysis revealed a normal 46,XX kary­
otype. Rearrangements of the dystrophy gen at Xp21 
were not found.
EMG revealed an increased number of brief 
polyphasic potentials with a small amplitude. Nerve 
conduction velocity was normal. EEG, VEP and BAEP 
were normal.
A biopsy from the quadriceps muscle at the age of 
18 months revealed dystrophic changes, such as 
rounded fibres, a wide variation in the fibre diameter 
and an increased amount of interstitial connective tis­
sue (Fig. 2A). There was no marked evidence of fibre 
necrosis and regenerative activity. Immunohistochem- 
istry with dystrophin antibodies showed a normal ex­
pression pattern (Fig, 2B).
Cerebral CT at the age of 18 months showed hypo­
densities in the white matter. At this age, MRI re­
vealed hypodensities in the periventricular areas of 
both occipital horns (Tl, sagittal) and hyperintensity of 
the white matter (T2). No progression in white matter 
hypodensities has been seen on CT/MRI during the 
past 3 years.
Clinical course was characterized by motor retarda­
tion, but with normal mental development.
3. Analysis of data on 17 CMD patients (Table 2)
Neuroradiological findings
Thirteen patients did not show abnormalities on 
their CT or MRI of the brain. In the 3 patients (cases 
15, 16 and 17) with white matter hypodensity on cere­
bral CT, the hypodensity was diffuse and could be 
confirmed in 2 of the 3 cases by MRI; in one patient, 
MRI was not available (case 16). The first neuroimag­
ing occurred at the age of 1.5, 13 and 16 years, respec­
tively. Follow-up was performed 3, 5 and 3 years later, 
respectively, There was no change or progression.
Clinical features
There were no clinical differences between CMD 
with and without white matter abnormalities.
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Fig. 2. Biopsy of quadriceps muscle stained with I-TE (A) and dystrophin antibody (B). Note the wide variation of muscle fibre diameters and the 
even distribution of dystrophin. Bar = 50 jj,m.
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Table 2
Signs and symptoms, 
hypodensities
laboratory, genetica], radiological and neurophysiological characteristics of 17 patients with “pure” congenital muscular dystrophy, 3 of whom had white matter
Case No.
“Pure” CMD
Without white matter 
hypodensity
1 2 3 4 5 6 7 8 9 10 11 12 13 14
With white matter
hypodensity
15 16 17
Age at muscle biopsy (yr) 0 0 1 1 1 2 3 3 3 3 4 5 6 14 3 6 1
Sex F M F F F M M M M M M M M M M M F
Consanguinity — — — + — — - — — - - — — — ■f —
Congenital hypotonia + + + + + + + + + + + + + + + + -f
Joint contractures — + — — + — — — — + + + —
Rapidly progressive course + — - + — - — — + — — — —
(motor retardation)
CK activity (normal < 100 U /l) 288 N N N N N N 143 N N 134 153 392 N 400 N 1178
DNA analysis np np np N np np N np np N np N N np N N N
Dystrophic muscular biopsy + + + + + + + + H- + - I -1 + + + + + +
CNS involvement
— CSF abnormalities np np N np N N N np N N np np N np np N N
— EEG abnormalities — — — np — — — + + — — — — — + + —
— convulsions /  epilepsy — — — — — — — — — — — — ~r + —
- hypomyelination (CT/MRI) np — — — — — — — — — — —
1 + +
— intelligence * N N N N N N N N N N N N N N N N N
N = normal; np = not performed; — — absent; + = present. Normal intelligence = IQ >70.
Table 3
Review of previously reported cases (64) and our cases; (3) of congenital muscular dystrophy with (sub)normal intelligence and low density areas in the white matter.
(First) author (year of publication)
Bernier Nogen Egger Echen ne Martinelli Yoshioka Castro-Gago Streib Tanaka Kacinski Cook Pihko Donner * Topaloglu Our Total
(1979) (1980) (1983) (1986) (1987) (1987) (1988) (1989) (1990) (1992) (1992) (1992) (1994) cases
Number of cases 5 2 3 6 1 1 1 2 1 1 11 5 5 20 3 67
Male : female ratio 3 :2 0 :2 1 :2 4 :2 1 :0 1 :0 1 :0 1 : 1 1 :0 0: 1 4 :7 3 :2 nm 12:8 2:1 34:28
Weakness
- non progressive 5/5 2/2 2/3 4/6 0/1 1/1 i / i 2/2 i / i 1/1 2/11 5/5 nm 3/20 2/3 31/62
- progressive 0/5 0/2 1/3 2/6 1/1 0/1 0/1 0/2 0/1 0/1 9/11 0/5 nm 17/20 1/3 31/62
Epilepsy 1/5 0/2 1/3 2/6 1/1 0/1 0/1 2/2 0/1 0/1 0/11 2/5 3/5 1/20 2/3 15/67
IQ  >70 5/5 0/2 3/3 1/6 1/1 1/1 1/1 2/2 1/1 1/1 9/11 5/5 5/5 11/13 3/3 49/60
50-70 0/5 2/2 0/3 5/6 0/1 0/1 0/1 0/2 0/1 0/1 2/11 0/5 0/5 2/13 0/3 11/60
Other clinical signs
- dysmorphic features * * 0/5 0/2 0/3 0/6 0/1 1/1 0/1 0/2 0/1 0/1 0/11 0/5 nm 8/20? 0/3 9/62
- pyramidal syndrome 0/5 0/2 0/3 0/6 0/1 0/1 0/1 1/2 0/1 0/1 0/11 0/5 nm 0/20 0/3 1/62
Epileptic EEG 1/5 0/2 1/3 2/4 1/1 0/1 0/1 2/2 0/1 0/1 1/4 5/5 nm 8/20? 2/3 23/53
F = female; M = male; nm = not mentioned- * See Dubowitz 1994. 
chest.
*  *
Dysmorphic features, such as (long and) thin face, high arched palate, abnormalities of jaw articulation, and pigeon
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EEG and epilepsy
In cases 8 and 9, generalized spike-wave paroxysms 
occurred during sleep. In case 8, there were also some 
spikes of short duration in the central regions, while in 
case 9, paroxysmal sharp theta waves were found, but 
these electrical phenomena were not associated with 
seizures.
Two patients with white matter hypodensities (cases 
16 and 17) had poor rhythmic background activity for 
their age. In cases 16 and 17, the following were noted: 
multifocal discharges, diffuse slowing of the back­
ground activity and paroxysmal epileptic discharges, 
such as bilateral irregular sharp theta waves which 
were sometimes mingled with spikes. Both patients had 
clinical seizures. Case 16 had suffered from two gener­
alized tonic-clonic epileptic seizure at the age of 20 
years, while case 17 had suffered partial complex 
seizures sometimes with secondary generalization from 
the age of 2 years onwards. Seizures could be treated 
successfully using conventional antiepileptic drugs.
La bora to ry findings
In 16 out of our 17 patients, serum CK activity 
appeared to be normal or slightly increased. One case 
(case 17) with cerebral white matter hypodensity had 
markedly increased CK activity.
All the CSF parameters, including cell count, pro­
tein content, protein electrophoresis, immuno-electro- 
phoresis, myelin basic protein, lactate and pyruvate 
levels, were within normal ranges.
Genetics
The male/female ratio was 12:5. In 2 patients, con­
sanguinity could be proved (case 5, 8th—9th generation; 
case 17, second cousins).
DNA analysis was performed on 6 boys and 2 girls. 
Rearrangements of the dystrophy gen at Xp21 were 
not found.
4. Discussion
Congenital muscular dystrophy may be associated 
with more or less marked disorders of cerebral devel­
opment. There are three subtypes (Dubowitz, 1994): 
classic or “pure” CMD, F-CMD and MEB-D. 
Topaloglu et al. (1994) believe that CMD with only 
white matter hypodensities on CT or MRI examination 
should be considered as an intermediate form. How­
ever, according to the opinion of most of the partici­
pants in a workshop on this topic (Dubowitz, 1994), 
cases with a (sub)normal IQ who show white matter 
hypodensities on CT or MRI, without major malforma­
tions, developmental and/or migration defects of CNS, 
should be included in the classic or “pure” form of 
CMD (see Table 1).
Table 2 shows a summary of the clinical data pub­
lished in the literature on patients with CMD, 
(sub)normal intelligence, and low density areas in the 
white matter. All 17 patients with CMD in our series 
showed normal intellectual development. Three had 
marked, diffuse hypodensity of the white matter on CT 
and/or MRI examination. There were no dysmorphic 
features and no pyramidal signs. Some reports men­
tioned dysmorphic features, such as a long and thin 
face, abnormalities of jaw articulation and a high arched 
palate (Yoshioka et al., 1987; Topaloglu et al., 1994). 
Although the authors of these reports suggested that 
these clinical aspects are specific, we believe that the 
facial dysmorphic features and high arched palate are 
not specific for this group, but they are frequently seen 
in myopathic children (Leyten et al., 1990). Topaloglu 
et al. (1994) reported clinical findings in 18 cases with 
“pure” CMD and 20 cases with (sub)normal IQ which 
show white matter hypodensity. The last group may 
tend to run a more severe course in the presence of 
significantly higher CK levels. This is in agreement 
with our findings.
EEG abnormalities are not uncommon in “pure” 
CMD. Spikes and slow waves, periodic complexes and 
focal spikes can be detected in the routine EEG 
recordings (Pihko et al., 1992; Topaloglu et al., 1994). 
In literature 21 of 50 studies cases with hypodensity of 
the white matter had abnormal recordings (see Table 
3). Two of our three patients (cases 15 and 16) had 
seizures and epileptic discharges on their EEG. In 
contrast, only 2 of the 14 remaining CMD cases (cases 
8 and 9) had epileptic EEG discharges without any 
seizures. However, only CT but no MRI examination 
of the brain had been performed on these patients, so 
we cannot exclude minor CNS deficit which can only 
be visualized using MRI.
The occurrence of epilepsy was mentioned in 13 out 
of 64 patients in the literature (Table 3). Based on the 
data presented in Table 3, it can be concluded that 
there is a significantly higher epilepsy ratio (1 : 4.5) in 
CMD patients with (sub)normal intelligence and asso­
ciated white matter hypodensities than in the normal 
population (1 : 150). This phenomenon cannot be ex­
plained by other neurological pathology. Therefore we 
believe that a mild form of epilepsy can be part of 
CMD with white matter hypodensities.
The nature and significance of the white matter 
changes remain obscure. Informative neuropathologi- 
cal data are scarce. There is only one report (Egger et 
al., 1983) which described two patients. One patient 
showed moderate focal subpial gliosis and good pres­
ervation of the cortical architecture in a brain biopsy 
from the right frontal lobe. The myelin sheaths were 
intact in the core of the convolution. In the white 
matter, there was obvious astrocytic proliferation. This 
patient had a WISC-IQ of 135 at the age of 8 years,
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but this had fallen to 90 at the age of 10 years. In the 
other patient in the report, microscopical examination 
showed patchy demyelination of the white matter of 
the centrum semiovale. The authors suggest that these 
neuropathologica! findings in themselves were not di­
agnostic, but the low density in the central areas of the 
brain on the CT scans may indicate a demyelinating 
process. One other case had spongy appearance of 
white matter on necropsy (Echenne et al., 1986). Malik 
et al. (1990) described a case with significant decrease 
in staining of myelin as compared with age-matched, 
normal control brains. Before the introduction of 
CT/MRI, other authors also found demyelination of 
the brain in congenital muscular dystrophy (Fowler and 
Manson, 1973). However, the lack of progression of 
white matter hypodensities on successive CT/MRI 
scans (Egger et al., 1983; Streib and Lucking, 1989; 
Cook et al., 1992; our study), the absence of progres­
sive neurological signs and symptoms, and the normal 
MBP findings in CSF in our patients, are all arguments 
in favour of a non-progressive cerebral white matter 
disorder. However long-term follow-up studies and 
neuropathological studies will be necessary to have 
more insight in this topic.
The histological findings in the muscle biopsy speci­
mens from CMD patients with (sub)normal intelligence 
and low density areas in the white matter reported in 
the literature and the findings in our series (Table 3) 
did not differ essentially from those described in “pure” 
CMD, F-CMD and MEB-D (Leyten et al., 1993). In 
their series, Topaloglu et al. (1994) found necrosis in 4 
patients with white matter hypodensity and not in 
“pure” CMD. In our series, only fat cell infiltration 
was found to be increased with increasing age in “pure” 
CMD (Leyten et aL, 1993). Therefore, muscle biopsies 
cannot discriminate between the subtypes of CMD.
In conclusion, the data published in the literature 
(Table 3) and our findings support the hypothesis that 
the “pure” form of CMD with (sub)normal mental 
development can be subdivided into two subtypes, i.e. 
those with and those without white matter hypodensi­
ties. However, considerable overlap is evident in clini­
cal and pathological presentations. The subtype with 
white matter hypodensities tend to be clinically more 
severe (Topaloglu et al., 1994) and a mild form of 
epilepsy can be part of the clinical picture. The fea­
tures are not sufficient to consider this subtype of 
CMD as an separate entity between the “pure” form 
of CMD and the Fukuyama type of CMD (Dubowitz, 
1994).
Further research should aim to perform more MRI 
in a prospective longitudinal way, at different ages and 
on larger groups of children with CMD, and should 
include neuropathological examination of the hypo- 
dense white matter areas. Molecular genetic studies 
(“genetic mapping”) should help to clarify whether the
possible etiologic heterogeneity in the three subtypes 
of CMD is caused by allelic mutations of the same 
gene or by mutations in different genes. The responsi­
ble gene for the Fukuyama type of CMD has been 
localized at chromosome 9q31-33 (Toda et al, 1993) 
and we are probably now reaching the stage with CMD 
having clearly defined basic syndromes.
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